{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-053305","form_type":"8-K","ticker":"ELAN","cik":"0001739104","company_name":"Elanco Animal Health Inc","filed_at":"2025-05-28T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.525660+00:00","generated_at":"2026-05-20T08:22:09.552266+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Elanco appoints Robert VanHimbergen as CFO effective July 7, 2025","bullets":["Robert VanHimbergen appointed EVP and CFO, effective July 7, 2025; Todd Young stays as advisor through Aug 31, 2025.","VanHimbergen previously SVP and CFO of Hillenbrand; prior 15 years at Johnson Controls and PwC.","Base salary $660k, target annual cash incentive 75% of base, annual long-term incentive target $2.645M.","Make-whole awards: cash bonus $890k (3-year clawback) and RSU $1.735M (3-year ratable vesting).","Company reaffirmed Q2 and FY 2025 guidance issued May 7, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-053305","json":"https://secwatch.observer/filing/0001104659-25-053305.json","markdown":"https://secwatch.observer/filing/0001104659-25-053305.md","text":"https://secwatch.observer/filing/0001104659-25-053305.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1739104/000110465925053305/0001104659-25-053305-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1739104/000110465925053305/tm2516292d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T08:22:09.552266+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"67fd3ee5a2","claim":"Robert VanHimbergen was appointed as Executive Vice President and Chief Financial Officer at Elanco Animal Health Inc.","evidence_excerpt":"the Company announced the appointment of Robert (Bob) VanHimbergen as Executive Vice President and Chief Financial Officer, effective July 7, 2025.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1739104/000110465925053305/0001104659-25-053305-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Executive Vice President and Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"a98cadf66a","claim":"Todd Young changed role as Chief Financial Officer at Elanco Animal Health Inc.","evidence_excerpt":"Mr. VanHimbergen succeeds Todd Young who will continue to serve as an advisor, in a non-executive capacity, through August 31, 2025.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1739104/000110465925053305/0001104659-25-053305-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"succeeded"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}